Do brown tumors associated with severe hyperparathyroidism demonstrate FDG uptake on PET imaging?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Brown Tumors and FDG-PET Imaging

Yes, brown tumors associated with severe hyperparathyroidism demonstrate marked FDG uptake on PET imaging and can be indistinguishable from skeletal metastases. 1, 2, 3

Mechanism of FDG Uptake in Brown Tumors

Brown tumors are benign osteoclastic bone lesions that develop from excessive parathyroid hormone-driven bone resorption. The intense FDG avidity results from the high metabolic activity of accumulated giant cells and osteoclasts within these fibrous cystic lesions. 1, 2 This metabolic activity produces standardized uptake values (SUVs) that overlap significantly with those of malignant bone lesions, creating a diagnostic challenge when patients have concurrent malignancy. 3

Diagnostic Patterns on FDG-PET/CT

  • Brown tumors appear as osteolytic lesions with abnormally increased FDG uptake throughout the skeleton, often presenting as multiple focal lesions that mimic metastatic disease. 1, 2

  • The FDG uptake pattern in brown tumors cannot be reliably distinguished from bone metastases based on SUV values alone. 2, 3

  • 18F-FDG PET/CT demonstrates higher sensitivity for detecting brown tumors compared to Tc-99m MIBI scintigraphy or conventional bone scans. 4

Critical Diagnostic Algorithm

When encountering multiple FDG-avid osteolytic lesions in a patient with known or suspected malignancy:

Step 1: Check parathyroid hormone, calcium, alkaline phosphatase, and phosphate levels immediately. 1, 5 Elevated PTH (often >800 pg/mL) with hypercalcemia (>3.0 mmol/L) and hypophosphatemia strongly suggests hyperparathyroidism rather than metastatic disease. 4

Step 2: Perform Tc-99m MIBI parathyroid scintigraphy to localize parathyroid adenoma or hyperplasia. 1, 5 This functional imaging identifies the source of excess PTH production.

Step 3: Correlate FDG-PET findings with MIBI uptake patterns. 1 Parathyroid adenomas typically show MIBI avidity but may be non-FDG-avid, whereas brown tumors demonstrate both FDG and MIBI uptake. 1

Step 4: Obtain tissue diagnosis via CT-guided biopsy of an accessible lesion before initiating cancer therapy. 1, 2 Histopathology showing giant cells, hemosiderin deposits, and fibrous tissue without malignant features confirms brown tumor. 2, 3

Key Pitfalls to Avoid

Do not assume FDG-avid osteolytic lesions represent metastases in patients with known primary malignancy without checking PTH and calcium levels. 2, 3 The European Association of Nuclear Medicine guidelines emphasize that increased FDG uptake occurs in many benign inflammatory and metabolic bone processes, not just neoplastic lesions. 6

Do not rely on imaging characteristics alone to differentiate brown tumors from metastases. 3 Both entities produce lytic bone destruction with high FDG uptake and similar SUV ranges. 2

Recognize that brown tumors can coexist with true metastatic disease in cancer patients who develop concurrent hyperparathyroidism. 1 In such cases, MIBI-avid but non-FDG-avid lesions suggest parathyroid adenoma, while FDG-avid lymph nodes or soft tissue masses may represent true metastases. 1

Treatment Response Monitoring

Brown tumors regress following successful parathyroidectomy, with decreased FDG uptake and lesion size on follow-up PET/CT. 3 This metabolic response distinguishes brown tumors from metastases, which would not resolve after parathyroid surgery. Serial imaging 3-6 months post-operatively demonstrates progressive healing of the osteolytic lesions. 3

Intraoperative PTH monitoring confirms adequate parathyroid tissue resection, with levels dropping >50% from baseline within minutes. 1 Post-operative normalization of calcium and PTH levels correlates with subsequent brown tumor resolution on imaging. 3, 4

References

6
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

In an adult with progressive dysphagia to solids and liquids, weight loss, and no evidence of mechanical obstruction, how should achalasia be diagnosed and managed?
In a patient with chronic heart failure and volume overload, when is torsemide preferred over furosemide considering pharmacokinetics, dosing frequency, renal function, and cost?
Can a pediatric patient with a history of supraventricular tachycardia safely receive oseltamivir (Tamiflu) for influenza?
Could you elaborate on the WHO analgesic ladder for managing pain in adult cancer patients, including drug choices and dosing?
In a severely malnourished 1‑year‑old child with pneumonia and radiographic consolidation receiving ceftriaxone and gentamicin, should clindamycin be added for additional coverage?
In a patient with acute myocardial infarction who received streptokinase, can a second streptokinase dose be given one hour after the first dose if reperfusion has not been achieved?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question